BlackRock, Inc. 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-31 2:08 pm Purchase |
2023-12-31 | 13G | Karuna Therapeutics, Inc. KRTX |
BlackRock Inc. BLK |
2,015,374 5.300% |
151,056 (+8.10%) |
Filing |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Karuna Therapeutics, Inc. KRTX |
BlackRock Inc. BLK |
1,864,318 4.970% |
-539,095 (-22.43%) |
Filing |
| 2023-01-31 1:58 pm Purchase |
2022-12-31 | 13G | Karuna Therapeutics, Inc. KRTX |
BlackRock Inc. BLK |
2,403,413 7.000% |
764,796 (+46.67%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Karuna Therapeutics, Inc. KRTX |
BlackRock Inc. BLK |
1,638,617 5.500% |
238,362 (+17.02%) |
Filing |
| 2021-04-09 6:02 pm Purchase |
2021-03-31 | 13G | Karuna Therapeutics, Inc. KRTX |
BlackRock Inc. BLK |
1,400,255 4.800% |
26,543 (+1.93%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Karuna Therapeutics, Inc. KRTX |
BlackRock Inc. BLK |
1,373,712 5.100% |
1,373,712 (New Position) |
Filing |